I agree that this site is using cookies. You can find further informations here.
X
Endrenyi, Laszlo
79  results:
Search for persons X
?
1

Digging deeper into precision/personalized medicine: cracki..:

Özdemir, Vural ; Arğa, Kazım Yalçın ; Aziz, Ramy Karam...
OMICS A Journal of Integrative Biology.  , 2020
Link: https://hdl.handle.net/2..
 
?
2

Panos Macheras: a pioneering scientist in pharmaceutical sc..:

Endrenyi, Laszlo ; Bies, Robert R.
Journal of Pharmacokinetics and Pharmacodynamics.  46 (2019)  2 - p. 105-109 , 2019
Link: https://doi.org/10.1007/..
 
?
3

Summary report of second EUFEPS/AAPS conference on global h..:

Chen, Mei-Ling ; Blume, Henning ; Beuerle, Gerald...
European Journal of Pharmaceutical Sciences.  127 (2019)  - p. 24-28 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Bioequivalence metrics for absorption rates: linearity, spe..:

Tóthfalusi, László ; Endrényi, László ; Vincze, István
Acta Pharmaceutica Hungarica.  89 (2019)  1 - p. 17-21 , 2019
Link: https://doi.org/10.33892..
 
?
5

Interchangeability Of Biological Drug Products—FDA Draft Gu..:

Endrenyi, Laszlo ; Markus, Richard
Journal of Biopharmaceutical Statistics.  29 (2019)  6 - p. 1003-1010 , 2019
Link: https://doi.org/10.1080/..
 
?
6

Bioequivalence for highly variable drugs: regulatory agreem..:

Endrenyi, Laszlo ; Tothfalusi, Laszlo
Journal of Pharmacokinetics and Pharmacodynamics.  46 (2019)  2 - p. 117-126 , 2019
Link: https://doi.org/10.1007/..
 
?
7

Bioequivalence metrics for absorption rates: linearity, spe..:

Vincze, István ; Endrényi, László ; Tóthfalusi, László
http://real.mtak.hu/111802/1/6-ArticleText-216-3-10-20190801.pdf.  , 2019
Link: http://real.mtak.hu/1118..
 
?
8

Algorithms for evaluating reference scaled average bioequiv..:

Tothfalusi, Laszlo ; Endrenyi, Laszlo
Statistics in Medicine.  36 (2017)  27 - p. 4378-4390 , 2017
Link: https://doi.org/10.1002/..
 
?
9

The Two Main Goals of Bioequivalence Studies:

Endrenyi, Laszlo ; Blume, Henning H. ; Tothfalusi, Laszlo
The AAPS Journal.  19 (2017)  4 - p. 885-890 , 2017
Link: https://doi.org/10.1208/..
 
?
10

Biosimilar Clinical Development – Scientific Considerations..:

Endrenyi, Laszlo
Journal of Biopharmaceutical Statistics.  27 (2017)  6 - p. 1115-1117 , 2017
Link: https://doi.org/10.1080/..
 
?
11

An Exact Procedure for the Evaluation of Reference-Scaled A..:

Tothfalusi, Laszlo ; Endrenyi, Laszlo
The AAPS Journal.  18 (2016)  2 - p. 476-489 , 2016
Link: https://doi.org/10.1208/..
 
?
12

Guest editor's note: Special issue on biosimilarity assessm..:

Chang, Victoria Yu-Wei ; Endrenyi, Laszlo
Journal of Biopharmaceutical Statistics.  27 (2016)  2 - p. 195-196 , 2016
Link: https://doi.org/10.1080/..
 
?
13

Precision medicine 2.0: The rise of glocal innovation, supe..:

Dandara, Collet ; Endrenyi, Laszlo ; Kolker, Eugene...
Omics-A Journal of Integrative Biology.  , 2016
Link: https://hdl.handle.net/2..
 
?
14

An Exact Procedure for the Evaluation of Reference-Scaled A..:

Tothfalusi, Laszlo ; Endrenyi, Laszlo
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779113/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
15

Behavioural changes in mothers and maternally sensitised fe..:

Szabó, Éva R. ; Cservenák, Melinda ; Lutz, Thomas A....
Behaviour.  152 (2015)  12/13 - p. 1801-1819 , 2015
Link: https://www.jstor.org/st..
 
1-15